Artículos de revistas
Two Distinct Wt1 Mutations Identified In Patients And Relatives With Isolated Nephrotic Proteinuria
Registro en:
Biochemical And Biophysical Research Communications. , v. 441, n. 2, p. 371 - 376, 2013.
0006291X
10.1016/j.bbrc.2013.10.064
2-s2.0-84887998272
Autor
Guaragna M.S.
Lutaif A.C.G.B.
Piveta C.S.C.
Belangero V.M.S.
Maciel-Guerra A.T.
Guerra-Junior G.
De Mello M.P.
Institución
Resumen
Wilms' tumor type 1 gene (WT1) encodes a zinc-finger transcription factor that plays a key role during genitourinary development and in adult kidney. Mutations in exons 8 and 9 are associated with Denys-Drash Syndrome, whereas those occurring in the intron 9 donor splice site are associated with Frasier Syndrome. Familial cases of WT1 mutations are rare with only few cases described in the literature, whereas cases of WT1 mutations associated with isolated nephrotic proteinuria with or without focal segmental glomerular sclerosis (FSGS) are even rarer. Exons 8 and 9 of WT1 gene were analyzed in two non-related female patients and their parents. Patient 1, who presented with isolated nephrotic proteinuria and histologic pattern of FSGS, is heterozygous for the mutation c.1227 + 4C > T. This mutation was inherited from her mother, who had undergone kidney transplant due to FSGS. Patient 2 is heterozygous for the novel c.1178C > T transition inherited from her father. The putative effect of this nucleotide substitution on WT1 protein is p.Ser393Phe mutation located within the third zinc-finger domain. The patient and her father presented, respectively, isolated nephrotic proteinuria and chronic renal failure. These data highlight the importance of the inclusion of WT1 gene mutational analysis in patients with isolated nephrotic proteinuria, especially when similar conditions are referred to the family. © 2013 Elsevier Inc. All rights reserved. 441 2 371 376 Armstrong, J.F., Pritchard-Jones, K., Bickmore, W.A., The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo (1993) Mech. Dev., 40, pp. 85-97 Hammes, A., Guo, J.K., Lutsch, G., Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation (2001) Cell, 106, pp. 319-329 Wang, Z.Y., Qiu, Q.Q., Deuel, T.F., The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains (1993) J. Biol. Chem., 268, pp. 9172-9175 Moffett, P., Bruening, W., Nakagama, H., Antagonism of WT1 activity by protein self-association (1995) Proc. Natl. Acad. Sci. USA, 92, pp. 11105-11109 Rauscher, F.J., The WT1 Wilms tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor (1993) FASEB J., 7, pp. 896-903 Haber, D.A., Sohn, R.L., Buckler, A.J., Alternative splicing and genomic structure of the Wilms tumor gene WT1 (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 9618-9622 Morrison, A.A., Viney, R.L., Ladomery, M.R., The post-transcriptional roles of WT1, a multifunctional zinc-finger protein (2008) Biochim. Biophys. Acta, 1785, pp. 55-62 Bruening, W., Bardeesy, N., Silverman, B.L., Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development (1992) Nat. Genet., 1, pp. 144-148 Reddy, J.C., Morris, J.C., Wang, J., WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins (1995) J. Biol. Chem., 270, pp. 10878-10884 Denys, P., Malvaux, P., Van Den Berghe, H., Association of an anatomo-pathological syndrome of male pseudohermaphroditism, Wilms' tumor, parenchymatous nephropathy and XX/XY mosaicism (1967) Arch. Fr. Pediatr., 24, pp. 729-739 Drash, A., Sherman, F., Hartmann, W.H., A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease (1970) J. Pediatr., 76, pp. 585-593 Schumacher, V., Schärer, K., Wühl, E., Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations (1998) Kidney Int., 53, pp. 1594-1600 Barbaux, S., Niaudet, P., Gubler, M.C., Donor splice-site mutations in WT1 are responsible for Frasier syndrome (1997) Nat. Genet., 17, pp. 467-470 Klamt, B., Koziell, A., Poulat, F., Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms (1998) Hum. Mol. Genet., 7, pp. 709-714 Demmer, L., Primack, W., Loik, V., Frasier syndrome: A cause of focal segmental glomerulosclerosis in a 46, XX female (1999) J. Am. Soc. Nephrol., 10, pp. 2215-2218 Koziell, A., Charmandari, E., Hindmarsh, P.C., Frasier syndrome, part of the Denys Drash continuum or simply a WT1 gene associated disorder of intersex and nephropathy? (2000) Clin. Endocrinol., 52, pp. 519-524 Sambrook, J., Fristsch, E.F., (1989) Molecular Cloning: A Laboratory Manual, , 2nd ed. Cold Spring Harbor Lab Press New York Guaragna, M.S., De Lutaif, A.C.G., Bittencourt, V.B., Frasier syndrome: Four new cases with unusual presentations (2012) Arq. Bras. Endocrinol. Metabol., 56, pp. 525-532 Stoll, R., Lee, B.M., Debler, E.W., Structure of the Wilms tumor suppressor protein zinc finger domain bound to DNA (2007) J. Mol. Biol., 372, pp. 1227-1245 Ng, P.C., Henikoff, S., Predicting the effects of amino acid substitutions on protein function (2006) Annu. Rev. Genomics Hum. Genet., 7, pp. 61-80 Mathe, E., Olivier, M., Kato, S., Computational approaches for predicting the biological effect of p53 missense mutations: A comparison of three sequence analysis based methods (2006) Nucleic Acids Res., 34, pp. 1317-1325 Frasier, S.D., Bashore, R.A., Mosier, H.D., Gonadoblastoma associated with pure gonadal dysgenesis in monozygous twins (1964) J. Pediatr., 64, pp. 740-745 Loirat, C., André, J.L., Champigneulle, J., WT1 splice site mutation in a 46, XX female with minimal-change nephrotic syndrome and Wilms' tumour (2003) Nephrol. Dial. Transplant., 18, pp. 823-825 Tsuda, M., Owada, M., Tsuchiya, M., WT1 nephropathy in a girl with normal karyotype (46, XX) (1999) Clin. Nephrol., 51, pp. 62-63 Ruf, R.G., Schultheiss, M., Lichtenberger, A., Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome (2004) Kidney Int., 66, pp. 564-570 Mucha, B., Ozaltin, F., Hinkes, B.G., Mutations in the Wilms ' Tumor 1 Gene Cause Isolated Steroid Resistant Nephrotic Syndrome and Occur in Exons 8 and 9 (2006) Pediatr. Res., 59, pp. 325-331 Pritchard-Jones, K., Rahman, N., Gerrard, M., Familial Wilms tumour resulting from WT1 mutation: Intronic polymorphism causing artefactual constitutional homozygosity (2000) J. Med. Genet., 37, pp. 377-379 Kaplinsky, C., Ghahremani, M., Frishberg, Y., Familial Wilms' tumor associated with a WT1 zinc finger mutation (1996) Genomics, 38, pp. 451-453 Denamur, E., Bocquet, N., Mougenot, B., Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases (1999) J. Am. Soc. Nephrol., 10, pp. 2219-2223 Zirn, B., Wittmann, S., Gessler, M., Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy (2005) Am. J. Kidney Dis., 45, pp. 1100-1104 Regev, M., Kirk, R., Mashevich, M., Vertical transmission of a mutation in exon 1 of the WT1 gene: Lessons for genetic counseling (2008) Am. J. Med. Genet., 146 A, pp. 2332-2336 Fencl, F., Malina, M., Stará, V., Discordant expression of a new WT1 gene mutation in a family with monozygotic twins presenting with congenital nephrotic syndrome (2012) Eur. J. Pediatr., 171, pp. 121-124 Benetti, E., Caridi, G., Malaventura, C., A novel WT1 gene mutation in a three-generation family with progressive isolated focal segmental glomerulosclerosis (2010) Clin. J. Am. Soc. Nephrol., 5, pp. 698-702 Betts, M.J., Russel, R.B., Amino acid properties and consequences of substitutions (2003) Bioinformatics for Geneticists, pp. 289-316. , M.R. Barnes, I.C. Gray, John Wiley & Sons Ltd Pearson, R.B., Kemp, B.E., Protein kinase phosphorylation site sequences and consensus specificity motifs: Tabulations (1991) Meth. Enzymol., 200, pp. 62-81 Pavletich, N.P., Pabo, C.O., Zinc finger-DNA recognition: Crystal structure of a Zif268-DNA complex at 2.1 A (1991) Science, 252, pp. 809-817 Sakamoto, Y., Yoshida, M., Semba, K., Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain (1997) Oncogene, 15, pp. 2001-2012